Overexpressed eNOS upregulates SIRT1 expression and protects mouse pancreatic β cells from apoptosis
Tingting Hu1, Ye Chen2, Qian Jiang3
1Department of Biotechnology, Guilin Medical University, Guilin, Guangxi 541004, P.R. China.
Abstract:
Loss of sirtuin 1 (SIRT1) activity may be associated with metabolic diseases, including diabetes. The aim of the present study was to investigate the potential effects of overexpressed endothelial nitric oxide synthase (eNOS) on cell proliferation and apoptosis with SIRT1 activation in the Min6 mouse pancreatic β cell line. A pcDNA3.0-eNOS plasmid was constructed and transfected into Min6 cells for 24 h prior to harvesting. eNOS expression was validated and SIRT1 expression was detected following plasmid transfection using reverse transcription-quantitative polymerase chain reaction and western blot analysis, which demonstrated that the expression levels of eNOS and SIRT1 were significantly upregulated. Furthermore, the cell proliferation and cell apoptosis of the Min6 cells were evaluated, using a cell counting kit-8 assay and flow cytometry, respectively. The results suggested that overexpressed eNOS promoted cell proliferation and inhibited cell apoptosis in Min6 cells. The interaction between eNOS and SIRT1 was explored through co-immunoprecipitation, and it found that there was a strong interaction between eNOS and SIRT1. In conclusion, overexpressed eNOS may induce SIRT1 activation, which is implied to play a protective role in Min6 cells, and eNOS may be a new therapeutic target for diseases such as type 2 diabetes.
Insights
Overexpressed endothelial nitric oxide synthase (eNOS) promotes pancreatic beta cell proliferation and inhibits apoptosis by activating sirtuin 1 (SIRT1). This suggests eNOS may be a therapeutic target for type 2 diabetes.
Area of Science:
- Cell Biology
- Metabolic Diseases
- Molecular Biology
Background:
- Sirtuin 1 (SIRT1) activity loss is linked to metabolic diseases like diabetes.
- Endothelial nitric oxide synthase (eNOS) role in pancreatic beta cells is not fully understood.
Purpose of the Study:
- Investigate eNOS effects on Min6 cell proliferation and apoptosis.
- Examine the link between eNOS overexpression and SIRT1 activation.
Main Methods:
- Constructed and transfected pcDNA3.0-eNOS plasmid into Min6 cells.
- Validated eNOS and SIRT1 expression using RT-qPCR and Western blot.
- Assessed cell proliferation (CCK-8) and apoptosis (flow cytometry).
- Explored eNOS-SIRT1 interaction via co-immunoprecipitation.
Main Results:
- Overexpressed eNOS significantly upregulated both eNOS and SIRT1 expression.
- eNOS overexpression promoted Min6 cell proliferation.
- eNOS overexpression inhibited Min6 cell apoptosis.
- Confirmed a strong interaction between eNOS and SIRT1.
Conclusions:
- Overexpressed eNOS induces SIRT1 activation in Min6 cells.
- eNOS activation plays a protective role in pancreatic beta cells.
- eNOS represents a potential therapeutic target for type 2 diabetes.


